Dys-synchronous regulation of XPC and XPA in trigeminal ganglion neurons following cisplatin treatment cycles

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: Cancer cells may survive cis-diamminedichloroplatinum-II (cisplatin) DNA damage through synchronous mobilization of DNA repair proteins such as xeroderma pigmentosum C and A (XPC and XPA). However, non-cancerous neuronal cells exhibit hyper-vulnerability to cisplatin which is manifest as peripheral neurotoxicity. The purpose of the present study was to evaluate the effect of cisplatin on the immunolocalization of XPC and XPA in the trigeminal ganglion. Materials and Methods: Fischer344 rats were treated with two cycles of cisplatin (2 mg/kg/day, i.p.) and tissues were harvested for immunohistochemistry after each treatment cycle. Result: XPA immunoreactivity was evident after each treatment cycle, however, XPC immunoreactivity was suppressed following the second treatment cycle. Conclusion: The hyper-vulnerability of peripheral neurons to cisplatin chemotherapy may relate to the dys-synchronous regulation of XPC and XPA.

Original languageEnglish (US)
Pages (from-to)2637-2640
Number of pages4
JournalAnticancer Research
Volume28
Issue number5 A
StatePublished - Sep 2008
Externally publishedYes

Keywords

  • Cisplatin
  • Nucleotide excision repair
  • Trigeminal ganglion

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Dys-synchronous regulation of XPC and XPA in trigeminal ganglion neurons following cisplatin treatment cycles'. Together they form a unique fingerprint.

Cite this